<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jansen PAM</submitter><funding>Nederlandse Brandwonden Stichting</funding><pagination>682-692</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6760626</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(9)</volume><pubmed_abstract>The emergence of multidrug resistant bacteria has prioritized the development of new antibiotics. N-substituted pantothenamides, analogs of the natural compound pantetheine, were reported to target bacterial coenzyme A biosynthesis, but these compounds have never reached the clinic due to their instability in biological fluids. Plasma-stable pantothenamide analogs could overcome these issues. We first synthesized a number of bioisosteres of the prototypic pantothenamide N7-Pan. A compound with an inverted amide bond (CXP18.6-012) was found to provide plasma-stability with minimal loss of activity compared to the parent compound N7-Pan. Next, we synthesized inverted pantothenamides with a large variety of side chains. Among these we identified a number of novel stable inverted pantothenamid</pubmed_abstract><journal>The Journal of antibiotics</journal><pubmed_title>Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.</pubmed_title><pmcid>PMC6760626</pmcid><funding_grant_id>WO/16.101</funding_grant_id><pubmed_authors>Pennings LJ</pubmed_authors><pubmed_authors>Blaauw RH</pubmed_authors><pubmed_authors>Rutjes FPJT</pubmed_authors><pubmed_authors>Jansen PAM</pubmed_authors><pubmed_authors>Botman PNM</pubmed_authors><pubmed_authors>Cavina L</pubmed_authors><pubmed_authors>Sandrock J</pubmed_authors><pubmed_authors>Hermkens PHH</pubmed_authors><pubmed_authors>Schalkwijk J</pubmed_authors><pubmed_authors>de Heuvel E</pubmed_authors><pubmed_authors>Zeeuwen PLJM</pubmed_authors><pubmed_authors>van der Krieken DA</pubmed_authors><pubmed_authors>Raaijmakers EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.</name><description>The emergence of multidrug resistant bacteria has prioritized the development of new antibiotics. N-substituted pantothenamides, analogs of the natural compound pantetheine, were reported to target bacterial coenzyme A biosynthesis, but these compounds have never reached the clinic due to their instability in biological fluids. Plasma-stable pantothenamide analogs could overcome these issues. We first synthesized a number of bioisosteres of the prototypic pantothenamide N7-Pan. A compound with an inverted amide bond (CXP18.6-012) was found to provide plasma-stability with minimal loss of activity compared to the parent compound N7-Pan. Next, we synthesized inverted pantothenamides with a large variety of side chains. Among these we identified a number of novel stable inverted pantothenamid</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2026-05-06T21:29:45.134Z</modification><creation>2019-10-11T07:11:00Z</creation></dates><accession>S-EPMC6760626</accession><cross_references><pubmed>31171848</pubmed><doi>10.1038/s41429-019-0196-6</doi></cross_references></HashMap>